Morepen Laboratories - Quaterly Results

The revenue for the December 2025 quarter is pegged at Rs. 4575.72 millions, about 13.47% up against Rs. 4032.55 millions recorded during the year-ago period.Net profit showed a marginal rise at Rs. 234.96 millions for the quarter ended December 2025, as compared to corresponding quarter of last year.Operating profit surged to 458.23 millions from the corresponding previous quarter of 364.52 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202512	202412	% Var	202512	202412	% Var	202503	202403	% Var
Sales	4575.72	4032.55	13.47	12183.82	11725.98	3.90	15545.35	15375.94	1.10
Other Income	39.33	48.74	-19.31	126.78	125.77	0.80	157.20	125.66	25.10
PBIDT	458.23	364.52	25.71	1014.43	1358.30	-25.32	1691.31	1743.84	-3.01
Interest	43.07	12.66	240.21	122.25	33.60	263.84	71.03	35.09	102.42
PBDT	415.16	351.86	17.99	903.14	1324.70	-31.82	1620.28	1708.75	-5.18
Depreciation	100.94	48.08	109.94	286.75	121.88	135.27	244.42	219.00	11.61
PBT	314.22	303.78	3.44	616.39	1202.82	-48.75	1375.86	1489.75	-7.64
TAX	79.26	76.91	3.06	157.05	306.17	-48.70	360.10	380.40	-5.34
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	47.27	-4.36	-1184.17
PAT	234.96	226.87	3.57	459.34	896.65	-48.77	1015.76	1109.35	-8.44
Equity	1095.84	1095.84	0.00	1095.84	1095.84	0.00	1095.84	1022.27	7.20
PBIDTM(%)	10.01	9.04	10.79	8.33	11.58	-28.12	10.88	11.34	-4.07